Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza - Nutraceuticals World

What are you searching for?

Sign in
Regulations

Lonza

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Australian Authorities have approved Larch arabinogalactan from Lonza, Basel, Switzerland, as a therapeutically active ingredient for oral use. Three requirements were met to garner the approval: the ingredient arabinogalactan (Larix) is derived from Larix larcinia or Larix occidentalis; the concentration of polysaccharides in the ingredient is greater than or equal to 85%; and the maximum recommended daily dose of the ingredient does not exceed 15 grams. In Australia, Larch arabinogalactan had previously been approved as a food additive only.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics